InvestorsHub Logo
Followers 25
Posts 2345
Boards Moderated 0
Alias Born 06/20/2020

Re: None

Friday, 05/28/2021 11:19:38 PM

Friday, May 28, 2021 11:19:38 PM

Post# of 43402

Another drug may join list of FDA-authorized COVID treatments

https://www.usatoday.com/story/news/health/2021/05/28/covid-memorial-day-cvs-vaccine-variant-mask-cdc/7477992002/

Biopharmaceutical company Humanigen submitted their drug Lenzilumab to the Food and Drug Administration for emergency use authorization to treat hospitalized patients with COVID-19, the company announced Friday.

If authorized, the drug will join a growing list of treatments authorized by the FDA for COVID-19. Lenzilumab focuses on preventing and treating an overactive immune response commonly known as a “cytokine storm,” which causes the immune system to kill both healthy and diseased tissue.

In a Phase 3 study, the drug improved the likelihood of survival without ventilation by 54% in newly hospitalized patients. Survival improved by 92% in patients who also took certain steroids and remdesivir.

“There is a need for hospitalized patients who require supplementary oxygen,” said Dr. Cameron Durrant, Humanigen’s chief executive officer. “Treatments can be lifesaving; despite vaccinations, infections and significant breakthrough disease will continue.”

“There is a need for hospitalized patients who require supplementary oxygen,” said Dr. Cameron Durrant, Humanigen’s chief executive officer. “Treatments can be lifesaving; despite vaccinations, infections and significant breakthrough disease will continue.”


Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.